1887

Abstract

Heparan sulphate (HS) has been found to serve as receptor for initial cell binding of numerous viruses. Different glycosaminoglycans (GAGs), including heparin and HS, were analysed for their ability to bind swine vesicular disease virus (SVDV), a picornavirus with close homology to human coxsackie B5 virus. Binding of SVDV was established by heparin-affinity chromatography. In addition, infection of IB-RS-2 epithelial porcine cells was inhibited by treating the virus with soluble HS, heparin, and chondroitin sulphate B (CS-B), as well as by enzymic digestion of cell surface GAGs. Analysis of the infection course showed that SVDV uses cellular HS for its binding to the cell surface and that this interaction occurs during attachment of the virus, prior to its internalization into the cell. Sequence analysis of SVDV variants selected for their lack of sensitivity to heparin inhibition led to the identification of two residues (A2135V and I1266K) potentially involved in heparin/HS interaction. The location of these residues in a three-dimensional model shows that they are clustered in a well-exposed region of the capsid, providing a physical mechanism that could account for the heparin-binding phenotype.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.19603-0
2004-03-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/85/3/vir850653.html?itemId=/content/journal/jgv/10.1099/vir.0.19603-0&mimeType=html&fmt=ahah

References

  1. Asagoe T., Inaba Y., Jusa E. R., Kouno M., Uwatoko K., Fukunaga Y. 1997; Effect of heparin on infection of cells by equine arteritis virus. J Vet Med Sci 59:727–728
    [Google Scholar]
  2. Bahnemann H. G. 1975; Binary ethylenimine as an inactivant for foot-and-mouth disease virus and its application for vaccine production. Arch Virol 47:47–56
    [Google Scholar]
  3. Baranowski E., Ruiz-Jarabo C. M., Sevilla N., Andreu D., Beck E., Domingo E. 2000; Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: flexibility in aphthovirus receptor usage. J Virol 74:1641–1647
    [Google Scholar]
  4. Bernard K. A., Klimstra W. B., Johnston R. E. 2000; Mutations in the E2 glycoprotein of Venezuelan equine encephalitis virus confer heparan sulfate interaction, low morbidity, and rapid clearance from blood of mice. Virology 276:93–103
    [Google Scholar]
  5. Bernfield M., Gotte M., Park P. W., Reizes O., Fitzgerald M. L., Lincecum J., Zako M. 1999; Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68:729–777
    [Google Scholar]
  6. Borrego B., Carra E., Garcia-Ranea J. A., Brocchi E. 2002; Characterization of neutralization sites on the circulating variant of swine vesicular disease virus (SVDV): a new site is shared by SVDV and the related coxsackie B5 virus. J Gen Virol 83:35–44
    [Google Scholar]
  7. Byrnes A. P., Griffin D. E. 1998; Binding of Sindbis virus to cell surface heparan sulfate. J Virol 72:7349–7356
    [Google Scholar]
  8. Chen C. H., Wu R., Roth L. G., Guillot S., Crainic R. 1997; Elucidating mechanisms of thermostabilization of poliovirus by D2O and MgCl2 . Arch Biochem Biophys 342:108–116
    [Google Scholar]
  9. Chung C. S., Hsiao J. C., Chang Y. S., Chang W. 1998; A27L protein mediates vaccinia virus interaction with cell surface heparan sulfate. J Virol 72:1577–1585
    [Google Scholar]
  10. Compton T., Nowlin D. M., Cooper N. R. 1993; Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate. Virology 193:834–841
    [Google Scholar]
  11. Flynn S. J., Ryan P. 1996; The receptor-binding domain of pseudorabies virus glycoprotein gC is composed of multiple discrete units that are functionally redundant. J Virol 70:1355–1364
    [Google Scholar]
  12. Fromm J. R., Hileman R. E., Caldwell E. E., Weiler J. M., Linhardt R. J. 1995; Differences in the interaction of heparin with arginine and lysine and the importance of these basic amino acids in the binding of heparin to acidic fibroblast growth factor. Arch Biochem Biophys 323:279–287
    [Google Scholar]
  13. Fry E. E., Lea S. M., Jackson T. 7 other authors 1999; The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex. EMBO J 18:543–554
    [Google Scholar]
  14. Fry E. E., Knowles N. J., Newman J. W., Wilsden G., Rao Z., King A. M., Stuart D. I. 2003; Crystal structure of swine vesicular disease virus and implications for host adaptation. J Virol 77:5475–5486
    [Google Scholar]
  15. Garret R. H., Grisham C. M. 1995; Carbohydrates and cell surfaces. In Biochemistry pp  310–350
    [Google Scholar]
  16. Goodfellow I. G., Sioofy A. B., Powell R. M., Evans D. J. 2001; Echoviruses bind heparan sulfate at the cell surface. J Virol 75:4918–4921
    [Google Scholar]
  17. He Y., Lin F., Chipman P. R., Bator C. M., Baker T. S., Shoham M., Kuhn R. J., Medof M. E., Rossmann M. G. 2002; Structure of decay-accelerating factor bound to echovirus 7: a virus-receptor complex. Proc Natl Acad Sci U S A 99:10325–10329
    [Google Scholar]
  18. Hulst M. M., van Gennip H. G., Moormann R. J. 2000; Passage of classical swine fever virus in cultured swine kidney cells selects virus variants that bind to heparan sulfate due to a single amino acid change in envelope protein E(rns). J Virol 74:9553–9561
    [Google Scholar]
  19. Hulst M. M., van Gennip H. G., Vlot A. C., Schooten E., de Smit A. J., Moormann R. J. 2001; Interaction of classical swine fever virus with membrane-associated heparan sulfate: role for virus replication in vivo and virulence. J Virol 75:9585–9595
    [Google Scholar]
  20. Hung S. L., Lee P. L., Chen H. W., Chen L. K., Kao C. L., King C. C. 1999; Analysis of the steps involved in Dengue virus entry into host cells. Virology 257:156–167
    [Google Scholar]
  21. Jackson T., Ellard F. M., Ghazaleh R. A., Brookes S. M., Blakemore W. E., Corteyn A. H., Stuart D. I., Newman J. W., King A. M. 1996; Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. J Virol 70:5282–5287
    [Google Scholar]
  22. Jiménez-Clavero M. A., Douglas A., Lavery T., Garcia-Ranea J. A., Ley V. 2000; Immune recognition of swine vesicular disease virus structural proteins: novel antigenic regions that are not exposed in the capsid. Virology 270:76–83
    [Google Scholar]
  23. Jiménez-Clavero M. A., Escribano-Romero E., Douglas A. J., Ley V. 2001; The N-terminal region of the VP1 protein of swine vesicular disease virus contains a neutralization site that arises upon cell attachment and is involved in viral entry. J Virol 75:1044–1047
    [Google Scholar]
  24. Jiménez-Clavero M. A., Ley V., Fita I., Verdaguer N. 2003; Crystallization and preliminary X-ray analysis of swine vesicular disease virus (SVDV. Acta Crystallogr Sect D Biol Crystallogr 59:541–543
    [Google Scholar]
  25. Jusa E. R., Inaba Y., Kono M., Asagoe T., Uwatoko K. 1997; Effect of heparin on a haemagglutinin of porcine reproductive and respiratory syndrome virus. Res Vet Sci 62:261–264
    [Google Scholar]
  26. Kjellen L., Lindahl U. 1991; Proteoglycans: structures and interactions. Annu Rev Biochem 60:443–475 [erratum in Annu Rev Biochem 61, following viii]
    [Google Scholar]
  27. Krusat T., Streckert H. J. 1997; Heparin-dependent attachment of respiratory syncytial virus (RSV) to host cells. Arch Virol 142:1247–1254
    [Google Scholar]
  28. Lee E., Lobigs M. 2002; Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus. J Virol 76:4901–4911
    [Google Scholar]
  29. Lookene A., Chevreuil O., Ostergaard P., Olivecrona G. 1996; Interaction of lipoprotein lipase with heparin fragments and with heparan sulfate: stoichiometry, stabilization, and kinetics. Biochemistry 35:12155–12163
    [Google Scholar]
  30. Martino T. A., Petric M., Weingartl H. 9 other authors 2000; The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus. Virology 271:99–108
    [Google Scholar]
  31. Mettenleiter T. C., Zsak L., Zuckermann F., Sugg N., Kern H., Ben-Porat T. 1990; Interaction of glycoprotein gIII with a cellular heparinlike substance mediates adsorption of pseudorabies virus. J Virol 64:278–286
    [Google Scholar]
  32. Mondor I., Ugolini S., Sattentau Q. J. 1998; Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans. J Virol 72:3623–3634
    [Google Scholar]
  33. Morton T. A., Myszka D. G., Chaiken I. M. 1995; Interpreting complex binding kinetics from optical biosensors: a comparison of analysis by linearization, the integrated rate equation, and numerical integration. Anal Biochem 227:176–185
    [Google Scholar]
  34. Nardelli L., Lodetti E., Gualandi G. L., Burrows R., Goodridge D., Brown F., Cartwright B. 1968; A foot and mouth disease syndrome in pigs caused by an enterovirus. Nature 219:1275–1276
    [Google Scholar]
  35. Okazaki K., Matsuzaki T., Sugahara Y. 7 other authors 1991; BHV-1 adsorption is mediated by the interaction of glycoprotein gIII with heparinlike moiety on the cell surface. Virology 181:666–670
    [Google Scholar]
  36. O'Shannessy D. J., Brigham-Burke M., Soneson K. K., Hensley P., Brooks I. 1993; Determination of rate and equilibrium binding constants for macromolecular interactions using surface plasmon resonance: use of nonlinear least squares analysis methods. Anal Biochem 212:457–468
    [Google Scholar]
  37. Qiu J., Handa A., Kirby M., Brown K. E. 2000; The interaction of heparin sulfate and adeno-associated virus 2. Virology 269:137–147
    [Google Scholar]
  38. Reddi H. V., Lipton H. L. 2002; Heparan sulfate mediates infection of high-neurovirulence Theiler's viruses. J Virol 76:8400–8407
    [Google Scholar]
  39. Sa-Carvalho D., Rieder E., Baxt B., Rodarte R., Tanuri A., Mason P. W. 1997; Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle. J Virol 71:5115–5123
    [Google Scholar]
  40. Seechurn P., Knowles N. J., McCauley J. W. 1990; The complete nucleotide sequence of a pathogenic swine vesicular disease virus. Virus Res 16:255–274
    [Google Scholar]
  41. Stryer L. 1995; Hidratos de carbono. In Bioquímica , 4th edn. pp  472–481 Edited by Reverté.
    [Google Scholar]
  42. Summerford C., Samulski R. J. 1998; Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol 72:1438–1445
    [Google Scholar]
  43. Trybala E., Bergstrom T., Spillmann D., Svennerholm B., Flynn S. J., Ryan P. 1998; Interaction between pseudorabies virus and heparin/heparan sulfate. Pseudorabies virus mutants differ in their interaction with heparin/heparan sulfate when altered for specific glycoprotein C heparin-binding domain. J Biol Chem 273:5047–5052
    [Google Scholar]
  44. Verdaguer N., Jimenez-Clavero M. A., Fita I., Ley V. 2003; Structure of swine vesicular disease virus: mapping of changes occurring during adaptation of human coxsackie B5 virus to infect swine. J Virol 77:9780–9789
    [Google Scholar]
  45. WuDunn D., Spear P. G. 1989; Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J Virol 63:52–58
    [Google Scholar]
  46. Zautner A. E., Korner U., Henke A., Badorff C., Schmidtke M. 2003; Heparan sulfates and coxsackievirus-adenovirus receptor: each one mediates coxsackievirus B3 PD infection. J Virol 77:10071–10077
    [Google Scholar]
  47. Zhang G., Haydon D. T., Knowles N. J., McCauley J. W. 1999; Molecular evolution of swine vesicular disease virus. J Gen Virol 80:639–651
    [Google Scholar]
  48. Zhu Z., Gershon M. D., Gabel C., Sherman D., Ambron R., Gershon A. 1995; Entry and egress of varicella-zoster virus: role of mannose 6-phosphate, heparan sulfate proteoglycan, and signal sequences in targeting virions and viral glycoproteins. Neurology 45:S15–S17
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.19603-0
Loading
/content/journal/jgv/10.1099/vir.0.19603-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error